Compounds > glycyrrhizic acid
Page last updated: 2024-08-21

glycyrrhizic acid and paclitaxel

glycyrrhizic acid has been researched along with paclitaxel in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (80.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR1
Shi, L; Tang, C; Yin, C1
Cai, Y; Li, GF; Liang, QY; Wang, SQ; Wang, YT; Yang, FH; Zhang, Q; Zhao, BX1
Hussain, M1
Hucho, T; Imhof, T; Isensee, J; Klein, I; Koch, M; Lehmann, HC; Müller, C; Wassermann, MK; Wiesen, MHJ1

Other Studies

5 other study(ies) available for glycyrrhizic acid and paclitaxel

ArticleYear
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
    Journal of medicinal chemistry, 2012, May-24, Volume: 55, Issue:10

    Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection

2012
Glycyrrhizin-modified O-carboxymethyl chitosan nanoparticles as drug vehicles targeting hepatocellular carcinoma.
    Biomaterials, 2012, Volume: 33, Issue:30

    Topics: Animals; Antineoplastic Agents; Carcinoma, Hepatocellular; Cell Death; Cell Line, Tumor; Chitosan; Drug Carriers; Drug Delivery Systems; Endocytosis; Female; Glycyrrhizic Acid; Humans; Liver; Liver Neoplasms; Mice; Nanoparticles; Paclitaxel; Particle Size; Rhodamines; Spectroscopy, Fourier Transform Infrared; Static Electricity; Subcellular Fractions; Tissue Distribution; Treatment Outcome; Tumor Burden

2012
Bioavailability enhancement of paclitaxel via a novel oral drug delivery system: paclitaxel-loaded glycyrrhizic acid micelles.
    Molecules (Basel, Switzerland), 2015, Mar-06, Volume: 20, Issue:3

    Topics: Administration, Oral; Animals; Anti-Inflammatory Agents; Antineoplastic Agents, Phytogenic; Biological Availability; Drug Carriers; Drug Delivery Systems; Drug Liberation; Glycyrrhizic Acid; Intestinal Absorption; Intestinal Mucosa; Jejunum; Male; Micelles; Paclitaxel; Rats; Rats, Sprague-Dawley; Tissue Distribution

2015
Molecular Dynamics Simulations of Glycyrrhizic Acid Aggregates as Drug-Carriers for Paclitaxel.
    Current drug delivery, 2019, Volume: 16, Issue:7

    Topics: Antineoplastic Agents, Phytogenic; Drug Carriers; Glycyrrhizic Acid; Molecular Dynamics Simulation; Paclitaxel

2019
Glycyrrhizic Acid Prevents Paclitaxel-Induced Neuropathy via Inhibition of OATP-Mediated Neuronal Uptake.
    Cells, 2023, 04-25, Volume: 12, Issue:9

    Topics: Glycyrrhizic Acid; Humans; Membrane Transport Proteins; Neurons; Organic Anion Transporters; Paclitaxel; Peripheral Nervous System Diseases

2023